After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Stocks turn mixed Wednesday as a rally in crude oil fails to provide an across-the-board lift.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
There is no shortage of opinions and politics as the House prepares for a vote Nov. 30 on 21st Century Cures Act.
Doug Kass shares his thoughts on the Trump world and how large-cap biotechs are doing.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.